Leading global law firm Baker McKenzie advised Swiss Similasan Group in connection with the establishment of a strategic alliance with France-based Laboratoires Thea S.A.S in the area of eye care products, in particular in the United States and Switzerland.
Similasan Group develops and produces homeopathic products and natural cosmetics. Originating in Switzerland in 1980, the Similasan brand has become popular across Europe and Similasan remedies are widely used and well-respected in North America.
Baker McKenzie advised Similasan Group on all legal and tax aspects of this transaction. The cross-border team from Switzerland and the US was led by Lukas Glanzmann (Partner, Zurich) and Alexander Fischer (Partner, Zurich) and further comprised of: M&A/Transactions: Alexander Blaeser (Senior Associate, Zurich), Daniel Kaelin (Associate, Zurich), Michael J. Fieweger (Partner, Chicago), Aidan Milstead (Associate, Chicago); Tax: Andrea Bolliger (Counsel, Zurich), Fabian Greutert (Associate, Zurich); Merger Control: Boris Wenger (Partner, Zurich), Roger Thomi (Associate, Zurich); and Intellectual Property: Julia Schieber (Senior Associate, Zurich).